2006 was a record year for business start-ups in Ireland.

The value of R&D coming out of US universities is increasing. And the question of exactly how Europe measures up in comparison may soon be answered.

The Drugs for Neglected Diseases initiative launched its first product, a new formulation of for treating malaria.

The UK’s two major public funders of stem cell research are to run a national public discussion about the controversial field of stem cell research.

The band of UK quoted tech commercialisation companies has another member. Ipso Ventures joined the AIM market, raising £4.5 million.